Progesterone blocking drugs?
This is mostly a question...why are there no progesterone blocking drugs out there for hormonal treatment the way there are estrogen blockers? I was organizing stuff today and looked at my Oncotype info again and my PR score is very high...so blocking progesterone should be beneficial, in theory. Are they too toxic? Curious if anyone knows anything about this.
Comments
-
With ER+ BC a high PR+ % is good. Anti hormonals are more effective against these types of cancer. The lower your PR is the higher your Oncotype score will be and more likely you'll need chemo. I've not read of any research for an anti hormonal for PR.
-
I did just see this about pr-antagonists. Most everything else I saw was about using PR blockers as contraception or to treat fibroids.
-
Doxie: Can you explain a little bit more about why the PR+ is good? I knew that ER+ was "good" because of Tamoxifen and AI's. I'm very interested to know because I had a PR at 100% but was not eligible for Oncotype DX. Thanks.
-
"The lower your PR is the higher your Oncotype score will be and more likely you'll need chemo."
I'd be interested in where this information came from. I have a negative PR, and I had a lowish onco score (18) and I didn't need chemo. I still haven't had chemo, even with the cancer in my bones, and have been stable for three years with just hormonal drugs, as I'm ER+.
I've never heard that the progesterone marker really had much to do with one's treatments. I'd love to read about that if you have a source.
-
The role of progesterone in breast cancer isn't very well understood from my research. It does seem that having progesterone receptors is a good thing for prognosis, but I haven't been able to find a great explanation as to why. The best I've found is that the presence of Progesterone Receptors indicates a functioning ER pathway (and therefore a target for tamoxifen) even in the absence of Estrogen Receptors. I do know that Megace, which is an artificial progestin, is sometimes used as a treatment for advanced breast cancer that no longer responds to tamoxifen. The description of Megace states that "it is not understood how it stops tumor growth, but it is assumed to interfere with estrogen". So it's interesting that a progestin is already given as a treatment, and now they're testing an anti-progesterone drug. There is speculation that the synthetic progestins in some birth control (Mirena, Nuvaring, etc) increase breast cancer risk. I'm sorry I'm not giving any answers, but this is something I've been wondering about for a while. I do know that my progesterone level was quite low when I got pregnant with my second child almost 8 years ago and I exhibited signs of "estrogen dominance" for years before BC, but I don't know if it's related. I also wonder about the other hormones in our bodies that affect breast development and function - testosterone (they are finding Androgen Receptors in some BC), prolactin, oxytocin, etc. I have a feeling that eventually they'll find there's more to this than ER/PR scores.
-
Sandlilee - the PR score is just one of the factors that goes into calculating the oncotype score. They break down the different genes into groups and multiply each group by a factor they somehow came up with to get the final score. PR is in the "ER related genes" group which is the only group to have a negative multiplier - the higher that group's score, the more it lowers the final result. So if you have low or absent PR expression, it will raise that part of the score. If the scores from the other groups are low, you can still end up with a low score of course - PR is just one piece of the puzzle.
The test was then validated using 675 node negative ER positive tamoxifen treated cases from NSABP B-14. In this analysis given classes of genes were given previously determined weighting factors and prognostic scores were calculated. The weightings would seem to make sense with proliferation, Her2 related, and invasion group genes increasing the score and ER related genes decreasing the score. The score was a continuous variable, but for the convenience of the presentation the patients were divided into 3 groups using cut points of 18 and 31.
-
Thank you for raising this issue. I've always wondered about the PR component.
-
lekker, thanks for doing a good job of answering the high and low PR+ question. When my BS talked about my pathology report he said "we like the PR % to be higher" so I did a lot of research on it. I too read that high PR+ makes Tamoxifen more effective. I'm on an AI, so the better treatment with for the BC I have. Sorry but that was 2.5 years ago now. I'll post this and look to see if I can find what I read. Looking at my oncotype report, if my PR had been as high as my ER, I would have had a more difficult decision to make about chemo.
Here are a couple.
-
I am new to this site and let's just say I am now becoming a member of this club. I have been diagnosed with ILC, grade 1, 13 mm, ER+ PR -. I recently had a MRI and they possibly found another tumor 9 mm. I am hoping that it is a false positive.
At any rate, the astonishing thing for me is women that initially had a 1cm tumor had a lumpectomy and shortly thereafter had a mastectomy. I am hoping for just a lumpectomy. I am confused why there are so many mastectomies when the tumors are grade 1 and 1cm. Everything I have been told is that I have an excellent prognosis with just a lumpectomy but will require constant surveillance every 6 mos.
I would appreciate some input on this issue. Thank you.
Johanne
-
Hi Johanne76. I am so sorry that you are on this site, but glad you found this site. I also had ILC and had an MRI before surgery to assess if there was any other cancer. That is very common with ILC as it is often mult focal or multi centric. MRI's are notorious for finding lots of things that are not cancer and that happened to me. I hope that your biopsy comes out B9 as mine did.You should be fine having a lumpectomy/radiation, but many women may need a mastectomy if the pathology from their lumpectomy surgery show positive margins (cancer at the edge of the tumor tissue) and they are not candidates for another try to get clear margins. And some women just change their minds for all kinds of reasons, fear or not wanting to have as close surveillance in the future, or they change their mind about radiation.
My surgeon recommended that I have a mastectomy only if I was BRCA+ (I was not) or the MRI detected additional cancer (It did not)....or if he was unable to get clear margins. (He did!)
I wish you the best as you begin this process.
Hugs, MsP
-
Hi Johanne, location of the tumor(s) matters too. If there are more than one tumors and they are in different quadrants mastectomy may be in order even if the tumors are small. Surgeon needs to get clear margins. -
Thank you so much for your responses. Of course, I am just a nervous wreck. This waiting game takes it toll. I have another question: I was told by my the oncologist that I interviewed that the ONCO test is not given to ILC patients. Is that correct? MSP thanks for telling me about the BRAC+ test.
Johanne
-
Johanne--many women are frustrated or lack confidence in the surveillance methods. My ILC was not picked up by mammogram. Even when I found it, it did not appear clearly on the mammo. Therefore, when I found out that even with what I had gone through, I would not qualify for an MRI routinely on the good breast, I took their strong advice to have a bilateral mastectomy. I was not a candidate for lumpectomy due to tumor size, which started at about 7 cm. But even in cases like those you've seen with much smaller tumors and lower stages, women just don't feel confidence with the current modes of detection, and in many cases rightfully so.
I did not receive the Oncotype DX test because I had a positive lymph node at diagnosis. It is my understanding that the Oncotype can be used on any type of breast cancer that is not lymph node positive.
-
Johanne, the oncotype test does not exclude ILC. I am not sure why your onc said that. The oncotype test is ordered for patients with hormone receptor positive breast cancer. Node status is not necessarily a criteria. This test examines your tumor's characteristics and helps you understand your risk of recurrence so you can make good decisions about things that can lower that risk. Most women use it to make a decision about chemo or no.
Genomics has a web site with more information on this test. Take a look.
MsP
-
Just to clarify: In my initial message I meant to say my doctor would have me under constant surveillance of my breast cancer every 6 mos for 5 years!!
My mind has been a bit foggie these days..
Johanne
-
This is really interesting. I am er really high and pr really low. From everything I have researched balancing the two is the ideal. Not 50/50 but balance so they work together. I wish the Dr.'s would tell us more about things like this but i don't think they even really know. I want to see if there is a way even with the Tamox to up the pr.
-
I believe that Oncotype has changed since 2011 to allow node positive patients, but I wonder if oncs are offering it. I could not get it from my onc in September 2011.
Regarding upping the progesterone, you really can't do that. The PR+ % refers to how many of the receptors on the cancer cells were sensitive to progesterone. There's no way to change that.
-
Mary, Thanks for clarifying that.
-
Johanne,
I also have ILC (though mine was larger and I had very close margins), node negative, ER/PR+. I had the oncotype test (and yes, I know they're now doing it for some women with one positive node). My score came back low, which meant no chemo. As far as I understand, oncotype can be used for both ILC and IDC.
I did have a double mastectomy (one side prophylactic) even though I am BRCA1/2 negative. The reasoning was, despite testing negative for the BRCA1/2 mutations, I have a strong family history (mom had pre-menopausal BC and she had a contralateral recurrence).
So... some of the reason you're seeing ILC with so many mastectomies is because ILC doesn't form defined tumors the same way that IDC does, doesn't show up on mammograms as often, and hence tends to be diagnosed later/larger. There is also some suggestion (though not definite) that ILC has a higher contralateral recurrence rate, or that at a minimum it is harder to detect than IDC. See if you can push for the oncotype, as it can give you one more piece of information about your tumor (especially since your PR status is negative, which I think is a little more unusal for ILC).
If your doctor is recommending a lumpectomy, rads and surveillance, that sounds like a good plan to me, and all the studies show similar survival rates with lump+rads vs mastectomy - but do look into whether alternating MRIs with mammograms is the plan for surveillance, as MRIs can detect things that mammograms miss, etc.
Best,
Lojo
-
When my mom had bc, I contacted a dr at Sloan who had a trial for a drug used in prostate cancer called "MDV" . I don't know much more about it except that my FIL was on the same drug for prostate cancer and it kept his advanced cancer at bay for over a year and a half.
-
Trial for a SPRM (like tamoxifen is a SERM)
-
My ER was 94% and PR < 10% so maybe that was one factor of why my Oncodx was 34. However the cancer was a very slow growing one, maybe the HER2 (+2) negative?
-
Meow13 - it's remarkable how similar or dx is. Moi - IDC 1.4 cm , Grade 3, 0/1 node, ER+ but barely PR (90% ER and 5% PR based on IHC) and Her2 negative. Oncotype score 39. The barely PR or negative PR with ER+ makes it luminal B, a bit more aggressive than luminal A breast cancer, but not as bad as a triple negative or her2+, though some would dispute her2+ being worse because there is herceptin for that.
It is curious that you didn't do chemo. But I'm more curious why you say the cancer was a "slow growing one?" My Ki67 (based on the biopsy) and a component in the Oncotype, was 60%, which indicates fast dividing cells. Were you ever given your Ki67??
I've seen a lot of journal articles mentioning much lower % of chemo or hormone blockers working for Luminal B, so you may have picked right on the chemo, at least for that reason.
-
My wife's PR score was also high at 95%.
I was also wondering why there aren't any therapies that exploit the progesterone receptor.
What's the deal here?
-
I had 70% er 6% pr and her2 negative. 6 nodes positive large tumor so no oncotype. I had to get chemo. No option there. No oncotype score but my ki-67 very low 9% and was a grade 2 My ki67 doesn't seem to correlate with a poorer prognosis. I did have the mirena removed a year before my breast cancer diagnosis. Funny that I had low pr after having the mirena for 6 years.
To lower my recurrency- I had full hysterectomy ( I am not brca positive) , take Metformin and zometa and arimidex. I am 44. Honestly- I have no idea what the numbers truly mean and figure I have done everything I possibly could to prevent it from coming back.
-
What are the drugs that exploit high progesterone receptor (PR) activity?
-
The benefits of being high PR+ is somewhat counterintuitive. Actually the higher the PR+ % generally the better the prognosis. Tamoxifen is not as effective with low PR % tumors, thus women are encouraged to take AIs and if necessary with ovarian suppression. Tumors with ER+, low PR, and high Ki67 are Luminal B. Generally chemo is suggested for these and there is a poor prognosis.
Somewhere on these boards there was a discussion on PR blocking drugs. Not sure where it is, but it may have been within the last 6 months or so.
-
After a bit of research, PR & ER are tied to each other. In a broad sense, it appears PR is a subset of ER. It sounds like PR is an estrogen regulated protein, so Tamoxifen not only blocks the Estrogen receptor (it's primary target), but also blocks the progesterone receptor in the process.
If your estrogen receptor isn't working (or is low), you'll have an inactive progesterone receptor as well.
My interpretation is that there is no need to PR specific drugs. Tamoxifen (if it's working properly and you don't have resistance) will work on the PR component as well.
-
https://www.sciencedaily.com/releases/2016/06/1606...
Cross talk between hormone receptors has unexpected effects
Finding suggests novel ways to improve breast cancer care
- Date:
- June 24, 2016
- Source:
- University of Chicago Medical Center
- Summary:
- Although the estrogen receptor is considered dominant in breast cancer, the progesterone receptor assumes control when both receptors are present and exposed to estrogens and progestins. Then, the progesterone receptor drives estrogen receptor activity. Treating tumor-bearing mice with an estrogen antagonist and a progestin antagonist caused rapid tumor regression, report scientists at the conclusion of their study.
Categories
- All Categories
- 679 Advocacy and Fund-Raising
- 289 Advocacy
- 68 I've Donated to Breastcancer.org in honor of....
- Test
- 322 Walks, Runs and Fundraising Events for Breastcancer.org
- 5.6K Community Connections
- 282 Middle Age 40-60(ish) Years Old With Breast Cancer
- 53 Australians and New Zealanders Affected by Breast Cancer
- 208 Black Women or Men With Breast Cancer
- 684 Canadians Affected by Breast Cancer
- 1.5K Caring for Someone with Breast cancer
- 455 Caring for Someone with Stage IV or Mets
- 260 High Risk of Recurrence or Second Breast Cancer
- 22 International, Non-English Speakers With Breast Cancer
- 16 Latinas/Hispanics With Breast Cancer
- 189 LGBTQA+ With Breast Cancer
- 152 May Their Memory Live On
- 85 Member Matchup & Virtual Support Meetups
- 375 Members by Location
- 291 Older Than 60 Years Old With Breast Cancer
- 177 Singles With Breast Cancer
- 869 Young With Breast Cancer
- 50.4K Connecting With Others Who Have a Similar Diagnosis
- 204 Breast Cancer with Another Diagnosis or Comorbidity
- 4K DCIS (Ductal Carcinoma In Situ)
- 79 DCIS plus HER2-positive Microinvasion
- 529 Genetic Testing
- 2.2K HER2+ (Positive) Breast Cancer
- 1.5K IBC (Inflammatory Breast Cancer)
- 3.4K IDC (Invasive Ductal Carcinoma)
- 1.5K ILC (Invasive Lobular Carcinoma)
- 999 Just Diagnosed With a Recurrence or Metastasis
- 652 LCIS (Lobular Carcinoma In Situ)
- 193 Less Common Types of Breast Cancer
- 252 Male Breast Cancer
- 86 Mixed Type Breast Cancer
- 3.1K Not Diagnosed With a Recurrence or Metastases but Concerned
- 189 Palliative Therapy/Hospice Care
- 488 Second or Third Breast Cancer
- 1.2K Stage I Breast Cancer
- 313 Stage II Breast Cancer
- 3.8K Stage III Breast Cancer
- 2.5K Triple-Negative Breast Cancer
- 13.1K Day-to-Day Matters
- 132 All things COVID-19 or coronavirus
- 87 BCO Free-Cycle: Give or Trade Items Related to Breast Cancer
- 5.9K Clinical Trials, Research News, Podcasts, and Study Results
- 86 Coping with Holidays, Special Days and Anniversaries
- 828 Employment, Insurance, and Other Financial Issues
- 101 Family and Family Planning Matters
- Family Issues for Those Who Have Breast Cancer
- 26 Furry friends
- 1.8K Humor and Games
- 1.6K Mental Health: Because Cancer Doesn't Just Affect Your Breasts
- 706 Recipe Swap for Healthy Living
- 704 Recommend Your Resources
- 171 Sex & Relationship Matters
- 9 The Political Corner
- 874 Working on Your Fitness
- 4.5K Moving On & Finding Inspiration After Breast Cancer
- 394 Bonded by Breast Cancer
- 3.1K Life After Breast Cancer
- 806 Prayers and Spiritual Support
- 285 Who or What Inspires You?
- 28.7K Not Diagnosed But Concerned
- 1K Benign Breast Conditions
- 2.3K High Risk for Breast Cancer
- 18K Not Diagnosed But Worried
- 7.4K Waiting for Test Results
- 603 Site News and Announcements
- 560 Comments, Suggestions, Feature Requests
- 39 Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts
- 4 Survey, Interview and Participant Requests: Need your Help!
- 61.9K Tests, Treatments & Side Effects
- 586 Alternative Medicine
- 255 Bone Health and Bone Loss
- 11.4K Breast Reconstruction
- 7.9K Chemotherapy - Before, During, and After
- 2.7K Complementary and Holistic Medicine and Treatment
- 775 Diagnosed and Waiting for Test Results
- 7.8K Hormonal Therapy - Before, During, and After
- 50 Immunotherapy - Before, During, and After
- 7.4K Just Diagnosed
- 1.4K Living Without Reconstruction After a Mastectomy
- 5.2K Lymphedema
- 3.6K Managing Side Effects of Breast Cancer and Its Treatment
- 591 Pain
- 3.9K Radiation Therapy - Before, During, and After
- 8.4K Surgery - Before, During, and After
- 109 Welcome to Breastcancer.org
- 98 Acknowledging and honoring our Community
- 11 Info & Resources for New Patients & Members From the Team